• Nenhum resultado encontrado

Rev. Assoc. Med. Bras. vol.62 número7

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Assoc. Med. Bras. vol.62 número7"

Copied!
2
0
0

Texto

(1)

LEAL GN ETAL.

616 REV ASSOC MED BRAS 2016; 62(7):616-617

AT THE BEDSIDE

Image-guided pancreatic biopsy; can we trust it as

a diagnostic alternative?

THIAGO QUEROZ1, WANDERLEY MARQUES BERNARDO2, MARCOS ROBERTODE MENEZES3

1MD, Radiologist, Hospital Sírio-Libanês, São Paulo, SP, Brazil 2Programa Diretrizes, Brazilian Medical Association

3MD, Coordinator of the Centro de Intervenção Guiada por Imagem, Hospital Sírio-Libanês, São Paulo, SP, Brazil

http://dx.doi.org/10.1590/1806-9282.62.07.616

I

NTRODUCTION

Most pancreatic adenocarcinomas are unresectable at the time of diagnosis,1 or present image limitations in the case of non-adenocarcinomas,2 thus posing a challenge for adequate histological sampling without the aid of laparoscopy. The American Joint Committee on Cancer considers the endoscopic ultrasound-guided diagnostic puncture as a procedure of choice.3 In recent years, with advances in imaging methods, computed tomography (CT) and percutaneous ultrasound have become a diag-nostic alternative in case of failure diagnosis, with the possibility of collecting histological fragments.4-8

M

ETHOD

Retrospective cohort analysis of hospital records of pa-tients undergoing ultrasound-guided percutaneous bi-opsy and/or CT scan based on positive or negative histo-logical indings in patients undergoing the percutaneous technique as irst alternative or after failure of an endo-scopic technique. We used the same pathology laborato-ries for the analysis of our histological fragments.

R

ESULTS

Fifty-ive image-guided percutaneous biopsies were included, 11 of which had undergone prior endoscopic

attempt with negative results. The average age was 62 years; 25 patients were male and 30 female. The mean size of the lesion was 4.75 cm, with 55% in the head and 45% in the body/tail of the pancreas. Positive results were possible in 85% of the cases, with 36 adenocarci-nomas; three B-cell lymphomas and four metastases (two gastrointestinal tract, one renal, one pulmonary); one epithelial microcystic lesion; two neuroendocrine tumors; and one chronic pancreatitis. Of the 11 cases of prior negative biopsy by endoscopy, we were able to reach a diagnosis in 72%, with seven adenocarcinomas and one epithelial microcystic lesion. All results were obtained with only a minor complication character-ized by a self-limited perihepatic hematoma. There was no tumor dissemination in the puncture needle path (Table 1).

C

ONCLUSION

In cases of negative endoscopic biopsies of pancreatic lesions, the ultrasound-guided percutaneous and/or CT method can be an effective and safe alternative for histo-logical diagnosis.

Keywords: cancer, biopsy, CT-guided biopsy, pancre-atic tumor.

TABLE 1 Positive results of image-guided percutaneous biopsies of pancreatic lesions.

Results Number of patients

Adenocarcinoma 36

Lymphoma 3

Metastasis* 4

Epithelial microcystic lesion 1

Neuroendocrine 2

Chronic pancreatitis 1

Total 47

(2)

IMAGE-GUIDEDPANCREATICBIOPSY; CANWETRUSTITASADIAGNOSTICALTERNATIVE?

REV ASSOC MED BRAS 2016; 62(7):616-617 617

R

EFERENCES

1. Goldin SB, Bradner MW, Zervos EE, Rosemurgy 2nd AS. Assessment of pancreatic neoplasms: review of biopsy techniques. J Gastrointest Surg. 2007; 11(6):783-90.

2. Bellizzi AM, Frankel WL. Pancreatic pathology: a practical review. Lab Med. 2009; 40(7):417-26.

3. Exocrine pancreas. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. American Joint Committee Cancer Staging Manual. 6. ed. New York: Springer; 2002. p. 157-64.

4. Werner B, Campos AC, Nadji M, Torres LFB. Uso prático da imuno-histoquímica em patologia cirúrgica. J Bras Patol Med Lab. 2005; 41(5): 353-64.

5. Paulsen SD, Nghiem HV, Negussie E, Higgins EJ, Caoili EM, Francis IR. Evaluation of imaging-guided core biopsy of pancreatic masses. AJR Am J Roentgenol. 2006; 187(3):769-72.

6. Amin Z, Theis B, Russell RC, House C, Novelli M, Lees WR. Diagnosing pancreatic cancer: the role of percutaneous biopsy and CT. Clinradiol. 2006; 61(12):996-1002.

7. Horwhat JD, Paulson EK, McGrath K, Branch MS, Baillie J, Tyler D, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc. 2006; 63(7):966-75.

Imagem

TABLE 1   Positive results of image-guided percutaneous biopsies of pancreatic lesions

Referências

Documentos relacionados

In our population, according to the current risk stratify- ing protocol based solely on age and previous history of thrombosis, 16 patients belonged to the low-risk and 30 to

The questionnaire contained questions about: the respondent’s stage of the course; what would be the most important item for medical training in the respondent’s opinion:

The BMI was calculated based on the formula: weight in kilograms divided by height in meters squared (kg/m 2 ). The patient and/or his guardian were asked about any

FIGURE 1 Annual number of transplants carried out at Hospital do Rim from August 18, 1998 to December 31, 2015, stratified by type of transplant: deceased, living, pediatric,

Clinical guidelines for the provision and as- sessment of nutrition support therapy in the adult critically ill patients: Society of Critical Care Medicine (SCCM) and American

Non-clinical studies, in turn, revealed attenuation of cytotoxicity, reduced apoptosis, protection of neoplastic cells against lipid peroxidation, modulation of markers of

Conclusion: The fetal thrombotic vasculopathy may be associated with adverse perinatal outcomes including fetal death, but much remains to be studied re- garding its

ATL affects about 5% of infected individuals and is classiied in the following clinical forms: acute, lymphoma, primary cutaneous tumoral, chronic (favorable and unfavor- able),